New York Office
Russell is an Executive Director at Torreya Partners and a member of our Principal Investment team. He is a physician with a Masters degree in public health and joined the firm with more than 37 years of leadership positions in biotech and pharma companies, in clinical development, safety, approval, regulatory interactions in major markets, and on the launch and growth of products across many therapeutic areas. Most recently he was CEO at Assembly Biosciences (NASDAQ:ASMB). Prior to these positions he has held positions at Fibrogen, Paramount Biosciences, and was CMO for the US at Sanofi-Synthelabo and Roche.